The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors in a phase I dose escalation study.
 
Jermaine Coward
Research Funding - AstraZeneca (Inst)
 
Anna Rachelle Austria Mislang
No Relationships to Disclose
 
Sophia Frentzas
No Relationships to Disclose
 
Charlotte Rose Lemech
No Relationships to Disclose
 
Adnan Nagrial
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Research Funding - Akeso Biopharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD Oncology (Inst)
 
Xiaoping Jin
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Baiyong Li
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Zhongmin Maxwell Wang
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Kon Yew Kwek
Employment - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma
 
Yu Xia
Employment - Akeso Biopharma
Leadership - Akeso Biopharma
Stock and Other Ownership Interests - Akeso Biopharma